AMN Healthcare Services (AMN) After AONL Move Looks Fully Valued Near $35

AMN Healthcare Services, Inc.

AMN Healthcare Services, Inc.

AMN

0.00

AMN Healthcare Services (AMN) recently joined the AONL Foundation Corporate Advisory Council, aligning its nursing leadership efforts with the company’s expansion into technology enabled workforce platforms and automation, which are influencing investor attention.

Over the past year, AMN Healthcare Services has seen a sharp shift in sentiment, with the share price climbing strongly, including a 21.09% 90 day share price return and 132.01% year to date share price return. The 1 year total shareholder return of 74.96% contrasts with weaker 3 and 5 year total shareholder returns. This indicates that recent momentum is rebuilding after a difficult few years as investors weigh its technology enabled workforce push and new nursing leadership partnerships against ongoing pressure in core staffing volumes and pricing.

Scan how AMN Healthcare Services compares with other fast moving workforce and automation plays by reviewing our curated list of 46 high quality undervalued stocks.

AMN Healthcare Services now combines a broad healthcare staffing platform with fast growing workforce technology offerings, and the share price has risen significantly in 2026. The next step is to test whether that strength is already fully priced.

Most Popular Narrative: 20% Overvalued

The most followed narrative values AMN Healthcare Services at $35.00, which is close to the last close of $35.08, and implies only a small margin for error given the assumptions behind that estimate.

The analysts have a consensus price target of $35.0 for AMN Healthcare Services based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $40.0, and the most bearish reporting a price target of just $26.0.

Want to see what justifies this tight gap between price and fair value? The narrative refers to shrinking revenues, much thinner margins, and a very demanding earnings multiple.

Result: Fair Value of $35 (OVERVALUED)

However, you still need to watch for weaker travel nurse volumes if higher job orders do not convert, as well as ongoing pricing pressure in language services that can squeeze margins.

Another View on AMN Healthcare Services Valuation

While the analyst narrative flags AMN Healthcare Services as overvalued around a $35 fair value, the current P/E of 12.9x tells a different story. It is much lower than peers at 27.4x and far above a fair ratio of 2.2x, which implies significant valuation risk if earnings underperform or sentiment cools.

To see how this pricing gap could close in practice, and what the numbers imply for future rerating risk, See what the numbers say about this price — find out in our valuation breakdown..

NYSE:AMN P/E Ratio as at Aug 2026
NYSE:AMN P/E Ratio as at Aug 2026

Next Steps

Mixed messages on AMN Healthcare Services so far? If you want to move quickly and build your own view from the ground up, start by weighing its 2 key rewards and 3 important warning signs.

Looking For More Investment Ideas Beyond AMN Healthcare Services?

If you are serious about making the most of what comes next, do not stop your research with AMN Healthcare Services. Broaden your watchlist using focused stock ideas.

  • Target income potential with companies that aim to sustain higher yields by reviewing our hand picked 12 dividend fortresses.
  • Spot resilient balance sheets before the crowd by checking the list of solid balance sheet and fundamentals (50 results).
  • Get ahead of under the radar opportunities by scanning the 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.